What We're Reading: Poorly Performing Hospitals Could Be Removed From Covered California
What we're reading, March 18, 2016: Covered California is considered removing hospitals with poor performance from the exchange; an outbreak in Wisconsin spreads to Michigan; #ZikaVirus infection in the US climbs to 450.
What We're Reading: Industry Money Linked to Increased Prescriptions of Brand Name Drugs
What we're reading, March 17, 2016: doctors who receive more industry money prescribe more brand name drugs; researchers project risk of Zika virus transmission in the US; and use of generic Gleevec could save $100,000 per patient.
What We're Reading: Rural Counties Struggle With Premature Death Rates
What we're reading, March 16, 2016: there is a big divide between the rural and urban health; exercise is rarely prescribed for chronic conditions; and NFL executive acknowledges link between football and degenerative brain disease.
What We're Reading: Sanders Proposes HIV/AIDS Drug Development Prize Fund
What we're reading, March 15, 2016: Bernie Sanders proposes a prize fund to spur drug development for HIV/AIDS; one news outlet is going to court to unseal documents related to OxyContin's marketing; and report highlights the emotional trauma healthcare providers face after making a serious medical error.
What We're Reading: Hospitals Get Creative to Combat Drug Price Increases
What we're reading, March 14, 2016: hospitals implement new ways to combat skyrocketing drug prices; some Affordable Care Act's health insurance co-ops could see profits in 2016; and patient anxiety decreases when hospitalists show more empathy.
What We're Reading: Prescription Drugs 16.7% of Overall Healthcare Spending
What we're reading, March 9, 2016: prescription drugs accounted for 16.7% of US healthcare spending in 2015; the FDA will allow Amarin to promote a prescription fish oil for off-label uses; and racial disparities for infant mortality persist.
What We're Reading: Big Decline in Rate of Unintended Pregnancies
What we're reading, March 8, 2016: rate of unplanned pregnancies in the US is at a 30-year low; doctors told they are overprescribing addictive medicines don't change their behavior; and despite Obamacare, surprise medical bills find a way.
What We're Reading: Urgent Care Used as a Bridge Between Primary Care and ER
What we're reading, March 7, 2016: urgent care is being used as a bridge between the primary care doctor's office and the emergency room; a task force calls for physicians to employ team-based care; and the government will meet to craft a plan for the Zika virus.
What We're Reading: 20 Million Gained Insurance Under the ACA
What we're reading, March 4, 2016: Since the passage of the Affordable Care Act, 20 million people have signed up for healthcare coverage; the FDA has a backlog of 4000 drug applications waiting for approval; and Flint, Michigan, receives expanded Medicaid coverage.
What We're Reading: $600M Funding for Opioid Abuse Bill Struck Down
What we're reading, March 3, 2016: additional funding for the opioid abuse bill was shot down in the Senate; Donald Trump releases his plan to replace Obamacare; and Christine Cassel, MD, discusses designing a new medical school.
What We're Reading: New FDA Head Vows More Efforts to Stem Opioid Abuse Epidemic
What we're reading, March 2, 2016: FDA commissioner pledges stronger efforts to develop harder-to-abuse painkillers; Olympus Corp. agrees to largest settlement for violating anti-kickback laws; and the Supreme Court hears Texas abortion case with just 8 members on the bench.
What We're Reading: ACA Program Led to Hospital Readmission Declines
What we're reading, February 29, 2016: hospital readmission declines tied to Obamacare program; Medicare negotiating powers may not have a large impact; and Aetna is on board with Affordable Care Act exchanges again.
What We're Reading: Pressure to Calculate the Price of Extending Life
What we're reading, February 26, 2016: drug makers are facing pressure to calculate the cost of extending a patient's life; a look at how addiction is viewed and treated in the US; and staving off the symptoms of Alzheimer's disease.
What We're Reading: Administration Will Crack Down on ACA Deadlines
What we're reading, February 25, 2016: the government will require proof of eligibility for enrollment in special sign-up periods under the Affordable Care Act (ACA); this year's flu vaccine is more effective; and 6 states are suing the Obama administration over an ACA fee.
What We're Reading: Drug Makers File Incomplete Side Effects Reports
What we're reading: drug makers are not reporting complete information about side effects; Johnson & Johnson will pay $72 million to the family of a woman who blamed her ovarian cancer on talcum powder; and Maine and Utah make new attempts at expanding Medicaid.
What We're Reading: CVS Reports Drug Spending Slowed Significantly
What we're reading, February 23, 2016: drug spending for CVS health plans slowed from 11.8% to 5%; CDC Director Tom Frieden, MD, MPH, talks Zika virus; and an investigation into the HealthCare.gov launch found widespread mismanagement.
Dr Mark Fendrick Testifying on Impact of VBID on TRICARE
The American Journal of Managed Care's co-editor-in-chief A. Mark Fendrick, MD, director of the University of Michigan Center for Value-Based Insurance Design (VBID), is testifying on how the principles of VBID and clinical nuance can contribute to healthcare reform in the US military health system.
What We're Reading: Seeking a Moratorium on New Drug Ads
What we're reading, February 22, 2016: new legislation proposes placing a 3-year moratorium on advertising newly approved drugs; the prevalence and incidence of stroke among young adults has increased significantly; and more women with breast cancer are choosing outpatient mastectomies.
What We're Reading: Long-Term Hospice Care Weighs on Medicare
What we're reading, February 19, 2016: long-term hospice care is weighing on Medicare; both the pope and the World Health Organization suggest women in Zika infected countries have access to contraception; and Texas health official steps down after co-authoring study on Planned Parenthood.